Warnings

NAD+

Attendu NAD+. Détecté Unable to Identify Insufficient sample for repeat analysis. Emplacement : Cheshire West and Chester (CH66), England. Date: 2026-05-11. Source : wedinos.wales.

Comprimé NAD+
Comprimé NAD+ — Cheshire West and Chester (CH66), England — 2026-05-11
Detected
Unable to Identify Insufficient sample for repeat analysis
Expected
NAD+
Logo
NAD+
Color
white
Location
Cheshire West and Chester (CH66), England
Date
2026-05-11
Source
wedinos.wales
Media
1 image

Appearance

  • Logo: NAD+
  • Color: white
  • Media: 1 sample photo

Detected Substances

  • Unable to Identify Insufficient sample for repeat analysis

Expected vs Detected

NAD+

Detected result: Unable to Identify Insufficient sample for repeat analysis

Sample Details

No additional sample descriptors available.

Testing Context

  • Location: Cheshire West and Chester (CH66), England
  • Date tested: 2026-05-11
  • Source: wedinos.wales

Harm Reduction

  • Similar-looking pills can contain different substances or strengths.
  • Use drug checking services when available.
  • Start low and avoid assuming a logo identifies the contents.

Links

This static page is intended as the readable export baseline for crawler and low-capability delivery.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for deeper analysis, filters, saved items, and mobile-first navigation.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

Alerte de test des drogues: Comprimé NAD+ — Unable to Identify (Insufficient sample for repeat analysis) dans Cheshire West and Chester (CH66), England

Comprimé NAD+. Attendu NAD+. Détecté Unable to Identify (Insufficient sample for repeat analysis). Emplacement : Cheshire West and Chester (CH66), England. Date: 2026-05-11. Source : wedinos.wales.

Recherchez des rapports sur les pilules, avertissements sur les comprimés d’ecstasy et de MDMA, alertes de vérification des drogues et contenus d’échantillons inattendus. Découvrez les substances et les risques.

Comprimé NAD+ — Unable to Identify (Insufficient sample for repeat analysis) — Cheshire West and Chester (CH66), England
Comprimé NAD+ — Unable to Identify (Insufficient sample for repeat analysis) — Cheshire West and Chester (CH66), England

Related pages